CANNABIS COMPANY BREAKS INTO $40B CHINESE MARKET

CANNABIS COMPANY BREAKS INTO $40B CHINESE MARKET

AUSTRALIAN medicinal cannabis company, Creso Pharma (ASX: CPH) has entered the lucrative Chinese food market after it signed a deal with a local hemp producer.

Creso Pharma has entered a strategic partnership with Zhejiang Kingdom Creative Co, a subsidiary of Hong Kong-listed company, Kingdom Group, to distribute Creso's products.

The agreement provides Creso with a strategic foothold in China, where the health food market is estimated to be worth $40 billion, and allows Kingdom Creative to expand its product offering into the healthcare sector and medical cannabis products.

Currently Kingdom Creative is primarily a hemp and flax-based production company.

Creso Pharma CEO and Co-founder, Dr Miri Halperin Wernli, says the group's agreement with Kingdom represents an important strategic moment.

"This is a very exciting partnership for Creso as it gives us a strategic foothold in China and Asia," says Wernli.

"Our collaboration with Kingdom Creative offers a great opportunity to work with a well-established and substantial organisation in this market."

Creso's break into the Chinese market follows the company's global expansion plans over the course of 2017.

In July, Creso broke into the North American market with the acquisition of Canadian cannbis production company Mernova Medicinal in exchange for $10.2 million worth of cash and equity.

The group also made its expansion into Europe after signing an exclusive commercialisation agreement with Virbac Switzerland to distribute hemp-based animal feed products.

Creso's move into the Chinese market should prove lucrative, considering the Chinese health food market is projected to grow by 10 per cent every year to 2025.

Following the agreement with Kingdom Group, Creso will open four new offices in China in Beijing, Shanghai, Shenzhen, and Guangzhou, giving it a sales and marketing presence and local distribution network for its products.

Kingdom Creative, as part of the agreement, will also build a health food, nutraceuticals, body care and cosmetic company.

The company says it is in discussions with other Asian pharmaceutical and cosmetics groups to bring Creso's products and IP to Asia to reach a massive population of consumers and patients.

At around 10.45am (AEDT) Creso Pharma shares were up 15.15 per cent to $1.14 per share.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Get our daily business news

Sign up to our free email news updates.

Please tick to verify that you are not a robot

 
Brother targets printer data security amid digital revolution in the office
Partner Content
The digital revolution may have changed the office forever, but the latest research sho...
Brother International Australia
Advertisement

Related Stories

Government deal to pass new IR laws leaves businesses shell-shocked

Government deal to pass new IR laws leaves businesses shell-shocked

An agreement with crossbenchers by the federal government to assure...

Venture capitalists back generative AI startup Leonardo.Ai to the tune of $47m

Venture capitalists back generative AI startup Leonardo.Ai to the tune of $47m

Sydney-based generative AI startup Leonardo.Ai, a platform that has...

Virtual reality medical training startup Vantari VR raises $7m

Virtual reality medical training startup Vantari VR raises $7m

An Australian virtual reality medical training technology is alread...

Seven West Media CEO Warburton announces shock exit amid industry challenges

Seven West Media CEO Warburton announces shock exit amid industry challenges

Seasoned media executive James Warburton is poised to wrap up five ...